Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
629 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04614129 | Lung Cancer Risk and Early Detection in Firefighters | completed | N/A | 734 | Massachusetts General HospitalOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT04900935 | Patient-centered, Optimal Integration of Survivorship and Palliative Care | recruiting | N/A | 70 | Massachusetts General HospitalOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT06331403 |
| Open Pilot Trial of a Mind-Body Sexual Well-Being Intervention for Female GI Cancer Survivors |
| completed |
| N/A |
| 6 |
| Massachusetts General HospitalOTHER |
| 1 |
| Nov 24, 2025 |
| clinicaltrials |
| NCT06132165 | Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas | completed | Phase 1 | 13 | Massachusetts General HospitalOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT05709912 | Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant | active not recruiting | N/A | 120 | Massachusetts General HospitalOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT06795529 | Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer(TARGET-PC) | recruiting | N/A | 400 | Massachusetts General HospitalOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07091032 | Building Connections | recruiting | N/A | 3,600 | Massachusetts General HospitalOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT02939300 | Ipilimumab and Nivolumab in Leptomeningeal Metastases | completed | Phase 2 | 18 | Massachusetts General HospitalOTHER | 1 | Nov 14, 2025 | clinicaltrials |
| NCT04656041 | Folfox+Irinotecan+Chemort In Esophageal Cancer | recruiting | Phase 2 | 40 | Massachusetts General HospitalOTHER | 1 | Nov 14, 2025 | clinicaltrials |
| NCT05524428 | Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study | recruiting | N/A | 2 | Massachusetts General HospitalOTHER | 1 | Nov 14, 2025 | clinicaltrials |
| NCT05912231 | Ultrahypofractionation and Normal Tissue Toxicity | active not recruiting | N/A | 60 | Massachusetts General HospitalOTHER | 1 | Nov 13, 2025 | clinicaltrials |
| NCT06757192 | CRC Screening in Unscreened Individuals 45-54 | recruiting | — | 40 | Massachusetts General HospitalOTHER | 1 | Nov 13, 2025 | clinicaltrials |
| NCT06763432 | Positive Fit to Colonoscopy: Closing the Gap(FACES) | recruiting | — | 45 | Massachusetts General HospitalOTHER | 1 | Nov 13, 2025 | clinicaltrials |
| NCT01180881 | Neurobehavioral Functioning in Pediatric Brain Tumor Patients After Proton Beam Radiation Treatment | completed | — | 155 | Massachusetts General HospitalOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT03674047 | Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT) | active not recruiting | Phase 2 | 50 | Massachusetts General HospitalOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT06472128 | Novel Digital Application for Patients With Acute Leukemia(NAVIGATE) | recruiting | N/A | 200 | Massachusetts General HospitalOTHER | 1 | Nov 10, 2025 | clinicaltrials |
| NCT03564821 | IDH1 Inhibition Using Ivosidenib as Maintenance Therapy for IDH1-mutant Myeloid Neoplasms Following Allogeneic Stem Cell Transplantation | completed | Phase 1 | 18 | Massachusetts General HospitalOTHER | 1 | Nov 4, 2025 | clinicaltrials |
| NCT05527392 | Virtual Health Insurance Navigation Pilot Program for Childhood Survivors (HINTII)(HINTII) | active not recruiting | N/A | 529 | Massachusetts General HospitalOTHER | 1 | Nov 3, 2025 | clinicaltrials |
| NCT04566302 | Pilot Study of Imaging Human Skin With High-Speed Spectrally Encoded Confocal Microscopy | completed | N/A | 16 | Massachusetts General HospitalOTHER | 1 | Oct 29, 2025 | clinicaltrials |
| NCT02422433 | Surveillance and Image-Guided Biopsy of the Esophagus Using an OFDI Capsule | active not recruiting | N/A | 130 | Massachusetts General HospitalOTHER | 1 | Oct 22, 2025 | clinicaltrials |
| NCT02947971 | Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System | recruiting | N/A | 120 | Massachusetts General HospitalOTHER | 1 | Oct 22, 2025 | clinicaltrials |
| NCT02994693 | Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy | active not recruiting | — | 100 | Massachusetts General HospitalOTHER | 1 | Oct 22, 2025 | clinicaltrials |
| NCT03459339 | Coordinating Center: Natural History of Barrett's Esophagus Using Tethered Capsule Endomicroscopy | active not recruiting | N/A | 500 | Massachusetts General HospitalOTHER | 1 | Oct 22, 2025 | clinicaltrials |
| NCT03546660 | Imaging of the Esophagus Using a SECM Capsule | withdrawn | N/A | 0 | Massachusetts General HospitalOTHER | 1 | Oct 22, 2025 | clinicaltrials |
| NCT03830801 | Pilot Study for OCT Guided In Vivo Laser Capture Microdissection for Assessing the Prognosis of Barrett's Esophagus(IVLCM) | recruiting | N/A | 30 | Massachusetts General HospitalOTHER | 1 | Oct 22, 2025 | clinicaltrials |
| NCT04561791 | Evaluation of Tethered Capsule Endomicroscopy as a Screening Tool for Barrett's Esophagus in the Primary Care Setting | enrolling by invitation | N/A | 650 | Massachusetts General HospitalOTHER | 1 | Oct 22, 2025 | clinicaltrials |
| NCT00977470 | Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations | active not recruiting | Phase 2 | 76 | Massachusetts General HospitalOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT03118466 | Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia | completed | Phase 2 | 41 | Massachusetts General HospitalOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT06472089 | BMT-CARE: Psychosocial Intervention for Transplant Caregivers(BMT-CARE) | recruiting | N/A | 800 | Massachusetts General HospitalOTHER | 1 | Oct 15, 2025 | clinicaltrials |
| NCT03515512 | IDH2 Inhibition Using Enasidenib as Maintenance Therapy for IDH2-mutant Myeloid Neoplasms Following Allogeneic Stem Cell Transplantation | completed | Phase 1 | 23 | Massachusetts General HospitalOTHER | 1 | Oct 14, 2025 | clinicaltrials |
| NCT05784922 | Health Opportunities and Promoters of Equitable Screening for Lung Cancer(HOPES) | recruiting | — | 2,000 | Massachusetts General HospitalOTHER | 1 | Oct 14, 2025 | clinicaltrials |
| NCT03244020 | LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology | enrolling by invitation | Phase 4 | 2,868 | Massachusetts General HospitalOTHER | 1 | Oct 3, 2025 | clinicaltrials |
| NCT05142345 | Care Transition Intervention for Hospitalized Patients With Advanced Cancer | completed | N/A | 286 | Massachusetts General HospitalOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT05755490 | PROWESS (PROstate Cancer Wearables Exercise and Structured Supports): A Pilot Supportive Care Intervention | completed | N/A | 14 | Massachusetts General HospitalOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT02826434 | Adjuvant PVX-410 Vaccine and Durvalumab in Stage II/III Triple Negative Breast Cancer | active not recruiting | Phase 1 | 22 | Massachusetts General HospitalOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT03563248 | Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer | active not recruiting | Phase 2 | 168 | Massachusetts General HospitalOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT04857684 | SBRT + Atezolizumab + Bevacizumab in Resectable HCC | active not recruiting | Early Phase 1 | 20 | Massachusetts General HospitalOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT01239381 | Individualized Stereotactic Body Radiotherapy of Liver Metastases | completed | N/A | 92 | Massachusetts General HospitalOTHER | 1 | Sep 30, 2025 | clinicaltrials |
| NCT06265272 | Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis | recruiting | — | 45 | Massachusetts General HospitalOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT05842603 | I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients | recruiting | N/A | 30 | Massachusetts General HospitalOTHER | 1 | Sep 25, 2025 | clinicaltrials |
| NCT04473937 | Radiation Post-CAR T in Refractory Lymphoma | terminated | N/A | 3 | Massachusetts General HospitalOTHER | 1 | Sep 24, 2025 | clinicaltrials |
| NCT03019003 | Oral Decitabine (ASTX727) and Durvalumab in Recurrent and/or Metastatic Head and Neck Cancer Patients | completed | Phase 1 | 13 | Massachusetts General HospitalOTHER | 1 | Sep 16, 2025 | clinicaltrials |
| NCT04794322 | Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer | recruiting | — | 250 | Massachusetts General HospitalOTHER | 1 | Sep 16, 2025 | clinicaltrials |
| NCT00976898 | Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma | completed | N/A | 83 | Massachusetts General HospitalOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT06541990 | Psychoeducational Intervention for Patients With Hepatocellular Carcinoma(HARMONY) | recruiting | N/A | 50 | Massachusetts General HospitalOTHER | 1 | Aug 29, 2025 | clinicaltrials |
| NCT04409002 | Niraparib + Dostarlimab + RT in Pancreatic Cancer | completed | Phase 2 | 18 | Massachusetts General HospitalOTHER | 1 | Aug 15, 2025 | clinicaltrials |
| NCT01063114 | Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma | completed | N/A | 90 | Massachusetts General HospitalOTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT04057365 | Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC) | terminated | Phase 2 | 15 | Massachusetts General HospitalOTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT05470920 | Genetic Testing Decision Aid | recruiting | N/A | 350 | Massachusetts General HospitalOTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT06412172 | The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP) | recruiting | — | 100 | Massachusetts General HospitalOTHER | 1 | Aug 12, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials